We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Biogen Inc | NASDAQ:BIIB | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.09 | -0.51% | 214.41 | 214.27 | 214.57 | 217.73 | 213.58 | 214.66 | 697,691 | 20:08:19 |
From Apr 2022 to Apr 2024
10:16 ET -- Eisai Co. and Biogen Inc. are among the most talked about companies in the U.S. across all news items in the last 12 hours, according to Factiva data. A study of the companies' closely-watched lecanemab candidate for Alzheimer's disease showed the drug slowed cognitive decline by 27% compared with a placebo over 18 months but was associated with swelling and bleeding in the brain, with researchers recommending further, longer study. Dow Jones & Co. owns Factiva. (colin.kellaher@wsj.com)
(END) Dow Jones Newswires
November 30, 2022 10:31 ET (15:31 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Biogen Chart |
1 Month Biogen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
